Enveric Biosciences, Inc.
ENVB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,758 | $2,850 | $4,294 | $2,241 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $65 | $0 | $0 |
| Other Curr. Assets | $408 | $392 | $540 | $494 |
| Total Curr. Assets | $4,166 | $3,307 | $4,835 | $2,735 |
| Property Plant & Equip (Net) | $197 | $241 | $267 | $306 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $42 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $197 | $241 | $267 | $348 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,362 | $3,548 | $5,102 | $3,083 |
| Liabilities | – | – | – | – |
| Payables | $684 | $1,041 | $669 | $522 |
| Short-Term Debt | $0 | $100 | $0 | $0 |
| Tax Payable | $0 | $0 | $7 | $261 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $222 | $223 | $508 | $707 |
| Total Curr. Liab. | $906 | $1,364 | $1,184 | $1,490 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $906 | $1,364 | $1,184 | $1,490 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $5 | $30 | $25 | $7 |
| Retained Earnings | -$112,652 | -$110,778 | -$108,259 | -$106,075 |
| AOCI | -$581 | -$574 | -$598 | -$595 |
| Other Equity | $116,684 | $113,506 | $112,750 | $108,255 |
| Total Equity | $3,456 | $2,185 | $3,918 | $1,593 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,362 | $3,548 | $5,102 | $3,083 |
| Net Debt | -$3,758 | -$2,750 | -$4,294 | -$2,241 |